Business Description
CollPlant Biotechnologies Ltd
ISIN : IL0004960188
Share Class Description:
CLGN: Ordinary Shares NewDescription
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.59 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.16 | |||||
| Debt-to-EBITDA | -0.2 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -1.89 | |||||
| Beneish M-Score | -9.21 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.6 | |||||
| 3-Year EBITDA Growth Rate | 7.7 | |||||
| 3-Year EPS without NRI Growth Rate | 10.1 | |||||
| 3-Year FCF Growth Rate | 23.3 | |||||
| 3-Year Book Growth Rate | 56.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 65.58 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 60.58 | |||||
| 9-Day RSI | 57.41 | |||||
| 14-Day RSI | 53.26 | |||||
| 6-1 Month Momentum % | -31.05 | |||||
| 12-1 Month Momentum % | -29.69 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.27 | |||||
| Quick Ratio | 6.14 | |||||
| Cash Ratio | 5.84 | |||||
| Days Inventory | 166.17 | |||||
| Days Sales Outstanding | 1391.13 | |||||
| Days Payable | 162.44 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -18 | |||||
| Shareholder Yield % | -0.01 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -209.43 | |||||
| Operating Margin % | -2671.26 | |||||
| Net Margin % | -2535.7 | |||||
| FCF Margin % | -508.85 | |||||
| ROE % | -61.54 | |||||
| ROA % | -51.35 | |||||
| ROIC % | -201.25 | |||||
| ROC (Joel Greenblatt) % | -233.63 | |||||
| ROCE % | -59.46 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 12.59 | |||||
| PS Ratio | 69.9 | |||||
| PB Ratio | 2.35 | |||||
| Price-to-Tangible-Book | 2.36 | |||||
| EV-to-EBIT | -1.81 | |||||
| EV-to-Forward-EBIT | -5.8 | |||||
| EV-to-EBITDA | -1.93 | |||||
| EV-to-Revenue | 48.36 | |||||
| EV-to-Forward-Revenue | 2.5 | |||||
| EV-to-FCF | -9.5 | |||||
| Price-to-Net-Current-Asset-Value | 3.35 | |||||
| Price-to-Net-Cash | 3.73 | |||||
| Earnings Yield (Greenblatt) % | -55.25 | |||||
| FCF Yield % | -7.2 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CLGN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CollPlant Biotechnologies Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.689 | ||
| EPS (TTM) ($) | -1.54 | ||
| Beta | 0.06 | ||
| Volatility % | 48.63 | ||
| 14-Day RSI | 53.26 | ||
| 14-Day ATR ($) | 0.32348 | ||
| 20-Day SMA ($) | 4.065094 | ||
| 12-1 Month Momentum % | -29.69 | ||
| 52-Week Range ($) | 3.31 - 6.99 | ||
| Shares Outstanding (Mil) | 11.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CollPlant Biotechnologies Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CollPlant Biotechnologies Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
CollPlant Biotechnologies Ltd Frequently Asked Questions
What is CollPlant Biotechnologies Ltd(CLGN)'s stock price today?
The current price of CLGN is $4.25. The 52 week high of CLGN is $6.99 and 52 week low is $3.31.
When is next earnings date of CollPlant Biotechnologies Ltd(CLGN)?
The next earnings date of CollPlant Biotechnologies Ltd(CLGN) is 2024-11-27.
Does CollPlant Biotechnologies Ltd(CLGN) pay dividends? If so, how much?
CollPlant Biotechnologies Ltd(CLGN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers